Trifluoromethyl Iodide: A Potent Chemical Compound Revolutionizing the Field of Chemistry
Trifluoromethyl iodide, often abbreviated as CF3I, is a remarkable chemical compound that has garnered significant attention within the scientific community.
May 15，2024 API
D-Sorbitol: Metabolism in Plants, Biosynthesis and Degradation
D-Sorbitol's synthesis, metabolism, and degradation impact plant osmotic regulation, stress responses, and fruit quality, crucial for crop enhancement via genetic engineering.
May 15，2024 API
Eugenol: Overview and its Biological Activities
Eugenol from clove oil exhibits antioxidant and antimicrobial properties, scavenging free radicals and disrupting bacterial membranes, suggesting potential for medical applications.
May 15，2024 API
The toxicity of Triethylene glycol
Triethylene glycol (TEG) has been used for natural gas dehydration, as a humectant, solvent, and chemical intermediate in synthesizing resins, plasticizers, lubricants, and polyurethanes.
May 14，2024 Organic reagents
The introduction of p-Phenylenediamine
PPD has a strong protein binding ability to penetrate deeply into the hair. It is widely used as an oxidizable hair dye for its free availability and low cost.
May 14，2024 Dyes and Pigments
What are the effects of Dibutyl phthalate on the human body?
Exposure to dibutyl phthalate (DBP) by all routes (i.e. inhalation, ingestion, dermal contact) is toxic to humans.
May 14，2024 API
What are the uses of Methylamine hydrochloride in different fields?
Methylamine hydrochloride is used as a synthetic raw material or pharmaceutical intermediate component in the manufacture of pharmaceuticals.
May 14，2024 API
Which Diseases is Elagolix FDA-Approved For?
In 2018, the U.S. Food and Drug Administration (FDA) approved elagolix (Orilissa?) for treating pain associated with endometriosis—the first and only pill specifically approved for endometriosis pain
May 14，2024 Drugs
Agomelatine: Benefits and Mechanism of action
Agomelatine is an orally active, selective agonist for the melatonin MTNR1A and MTNR1B receptors and a selective antagonist for the serotonin HTR2C receptor.
May 14，2024 Drugs